Submissions from 2023
The First Collective Examination of Immunosuppressive Practices Among American Intestine Transplant Centers, Nathaly Llore, Masato Fujiki, Maria Segovia, Syed-Mohammed Jafri, Mark Obri, Jedson Liggett, Alexander Kroemer, Cal Matsumoto, Jang Moon, Pierpaolo DiCocco, Gennaro Selvaggi, Jennifer Garcia, Armando Ganoza, Ajai Khanna, George Mazariegos, Danielle Wendel, Jorge Reyes, Dylan Ormsby, and Joshua Weiner
NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH SIGNIFICANT IMPAIRMENT OF WORK PRODUCTIVITY: DATA FROM THE GLOBAL NASH REGISTRY™, Zobair M. Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vincent Wai-Sun Wong, Marlen I. C Fernandez Sr., Vasily A. Isakov, Ajay K. Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian-Gao Fan, George V. Papatheodoridis, Maria Buti Sr., Wah Kheong Chan, Khalid Aida Alswat, Saeed S. Hamid, Ashwani K. Singal, Manuel Romero-Gómez, Stuart C. Gordon, Stuart Roberts, Mohamed El Kassas, Gamal Esmat, Marcelo Kugelmas, Janus Ong, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova, and Saleh Alqahtani
Submissions from 2022
Long-term outcomes of donation after cardiac death and living donor liver transplant for primary sclerosing cholangitis, Dilip Moonka, Toshihiro Kitajima, Tommy Ivanics, Kelly Collins, Michael Rizzari, Atsushi Yoshida, Marwan S. Abouljoud, and Shunji Nagai
Lean non-alcoholic fatty liver disease patients from the global NASH registry, Zobair Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vincent Wai-Sun Wong, Marlen Castellanos-Fernandez, Vasily Isakov, Ajay Kumar Duseja, Nahum Méndez-Sánchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian-Gao Fan, George Papatheodoridis, Wah-Kheong Chan, Khalid Alswat, Saeed Sadiq Hamid, Ashwani Singal, Manuel Romero Gomez, Stuart C. Gordon, Stuart Roberts, Mohamed El Kassas, Marcelo Kugelmas, Janus Ong, Saleh Alqahtani, Mariam Ziayee, Brian Lam, Issah Younossi, Andrei Racila, Linda Henry, and Maria Stepanova
Submissions from 2021
The effect of the COVID-19 pandemic in intestinal rehabilitation and transplant patients, initial results of an international survey, M Fernandez, M Cristina Segovia, D Dijkstra, G Herlenius, A Testro, L Sharkey, F Braun, C Rumbo, F Lacaille, P Friend, and Syed-Mohammed Jafri
Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies, Stuart C. Gordon, Palak Trivedi, Christopher Bowlus, Galambos Michael, Aparna Goel, Aliya Gulamhusein, Cynthia Levy, Guy Neff, Carmen Stanca, Douglas Thorburn, Bruce Bacon, Brian Borg, Yvonne Doerffel, Lisa Forman, Bradley Freilich, Liana Gheorghe, María S. González, Stephen Harrison, Jonathan Huang, Sook-Hyang Jeong, Seung U. Kim, John Lake, Joseph Odin, Won Y. Tak, Hillel Tobias, John M. Vierling, Ke Yang, Alexandra Steinberg, Yun-Jung Choi, Charles McWherter, and Marlyn J. Mayo
Role of surveillance biopsy frequency post intestine transplant: A tertiary care experience, Yervant Ichkhanian, Nemie Beltran, Shunji Nagai, and Syed-Mohammed Jafri
Extreme Hyponatremia as a Risk Factor for Early Mortality after Liver Transplantation in the MELD-Sodium Era, Tommy Ivanics, Shravan Leonard-Murali, Hassan Mouzaihem, Dilip Moonka, Toshihiro Kitajima, Sirisha Yeddula, T Shamaa, Michael Rizzari, Kelly Collins, Atsushi Yoshida, Marwan S. Abouljoud, and Shunji Nagai
A multicenter evaluation of the diagnosis, management and outcomes of adenovirus enteritis infection following intestine or multivisceral transplant, Syed-Mohammed Jafri, M Segovia, and J Weiner
Switching from tenofovir disoproxil fumarate and/or other oral antivirals to tenofovir alafenamide in virally suppressed CHB patients with moderate or severe renal impairment or ESRD on HD: final week 96 efficacy and safety results from a phase 2 study, H L.A. Janssen, P Lampertico, C-H Chen, J Heo, C Fournier, S H. Ahn, T Y.O. Tsang, C S. Coffin, Y-H Huang, G M. Reggiani, A J. Hui, M Elkhashab, C-Y Chen, Syed-Mohammed Jafri, S Tan, Y Zhao, V Suri, J F. Flaherty, A Gaggar, D Brainard, W-L Chuang, K Agarwal, E Gane, and Y-S Lim
Multicentre international evaluation of autoimmune hepatitis and liver transplantation: disease recurrence is associated with recipient features, type of immunosuppression and impaired outcomes, Aldo J. Montano-Loza, Vincenzo Ronca, Maryam Ebadi, Bettina Hansen, Gideon Hirschfield, Saleh Elwir, Mohamad Alsaed, Piotr Milkiewicz, Maciej K. Janik, Hanns-Ulrich Marschall, Maria A. Burza, Cumali Efe, Ali R. Caliskan, Murat Harputluoglu, Gökhan Kabacam, Debora R. Terrabuio, Fernanda Onofrio, Albert Pares, Laura P. Llovet, Murat Akyildiz, Cigdem Arikan, Michael P. Manns, Richard Taubert, Anna-Lena Weber, Thomas Schiano, Brandy Hayde, Piotr Czubkowski, Piotr Socha, Natalia Oldak, Nobuhisa Akamatsu, Atsushi Tanaka, Cynthia Levy, Eric F. Martin, Aparna Goel, Mai Sedki, Irena Jankowska, Toru Ikegami, Maria Rodriguez, Martina Sterneck, Christina Weiler-Normann, Christoph Schramm, Maria F. Donato, Ansgar W. Lohse, Raul J. Andrade, Alan Bonder, Vilas Patwardhan, Bart Van Hoek, Maaike Biewenga, Andreas E. Kremer, Yoshihide Ueda, Mark Deneau, Mark Pedersen, Marlyn J. Mayo, Annarosa Floreani, Patrizia Burra, Maria F. Secchi, Benedetta T. Beretta-Piccoli, Marco Sciveres, Giuseppe Maggiore, Syed-Mohammed Jafri, Dominique Debray, Muriel Girard, Florence Lacaille, Ellina Lytvyak, Andrew L. Mason, Michael Heneghan, and Ye Htun Oo
Impact of PHQ-9 Screen on Early Identification of Depression in IBD Clinic, Ankita Nagirimadugu, Armani Patel, Faisal M. Nimri, Maher Musleh, Sandra Naffouj, Alexis Faber, Mouhanna Abu Ghanimeh, and Nirmal Kaur
Quality of trace mineral monitoring and replacement for patients on teduglutide for short bowel syndrome, Austin H. Qasawa, Nemie Beltran, Shunji Nagai, Yakir Muszkat, and Syed-Mohammed Jafri
Submissions from 2020
LONG TERM USE OF URSODIOL IN POST-LIVER TRANSPLANT PATIENTS INCREASES BILIARY COMPLICATIONS, Taha Ashraf, Vivek Mendiratta, Sonika Gill, Abdelwahab Ahmed, and Syed-Mohammed Jafri
PRIMARY CARE VISITS ARE THE KEY FACTOR IN ENSURING HIGHER VACCINATION RATES IN POST-LIVER TRANSPLANT PATIENTS. A SINGLE CENTER STUDY, Taha Ashraf, Vivek Mendiratta, Maher Musleh, Tommy Parraga Acosta, George Alangaden, Kimberly Brown, and Syed-Mohammed Jafri
LONG-TERM SAFETY OF SIROLIMUS IN LIVER TRANSPLANT RECIPIENTS, Taha Ashraf, Mohammad A. Siddiqui, Kamal Khorfan, and Dilip Moonka
Thirty-day incidence of post-ERCP complications: Incidence, risk factors and outcomes, A Bhurwal, H R. Mutneja, Khwaja F. Haq, S Solanki, R Chandra Chakinala, M J. Bartel, and B Brahmbhatt
. IMPACT OF RACE AND ETHNICITY ON PROGNOSTIC MODELS OF OUTCOMES IN PRIMARY SCLEROSING CHOLANGITIS, Christopher L. Bowlus, David Assis, Jialin Wu, Cynthia Levy, David S. Goldberg, Lisa Forman, Barry Schlansky, Craig Lammert, Stacey Prenner, K. Rajender Reddy, Stuart C. Gordon, Joseph Ahn, Joseph B. Zepeda, Marina G. Silveira, James L. Boyer, and Brad H. Pollock
THE IMPACT OF HCC LOCOREGIONAL THERAPY ON PERI-OPERATIVE AND POST-TRANSPLANT COMPLICATIONS, Allyce Caines, Kajali Mishra, Sara Stanley, Scott Sturza, Marwan S. Abouljoud, and Reena Salgia
PATIENT CHARACTERISTICS AND EFFICACY OF PANGENOTYPIC DIRECT-ACTING ANTIVIRAL REGIMENS AMONG A COHORT OF CHRONIC HEPATITIS C PATIENTS RECEIVING ROUTINE CLINICAL CARE IN THE US, Stuart C. Gordon, Jia Li, A C. Moorman, P R. Spradling, E H. Teshale, J A. Boscarino, Y Daida, M A. Schmidt, Yueren R. Zhou, Loralee B. Rupp, Sheri Trudeau, and Mei Lu
RISK FACTORS FOR SARS-COV-2 INFECTION AMONG PATIENTS WITH CHRONIC VIRAL HEPATITIS, Stuart C. Gordon, Loralee B. Rupp, J A. Boscarino, Y Daida, M A. Schmidt, Yueren Zhou, Sheri Trudeau, Jia Li, and Mei Lu
Safety and efficacy of endoscopic transpapillary gallbladder stenting for symptomatic gallbladder disease in cirrhosis: A systematic review and meta-analysis, U Iqbal, Khwaja F. Haq, H S. Khara, R N. Shah, M A. Khan, Mohammad A. Siddiqui, Y Hu, Mouhanna K. Abu Ghanimeh, Omar Sadiq, Andrew Watson, Reena Salgia, and Tobias Zuchelli
Post endoscopic retrograde cholangiopancreatography pancreatitis prevention using topical epinephrine: A systematic review and meta-analysis, U Iqbal, O Siddique, H S. Khara, M A. Khan, Khwaja F. Haq, S Solanki, Mohammad A. Siddiqui, Tobias Zuchelli, M J. Shellenberger, and J Birk
Comparison of per-oral endoscopic myotomy and pneumatic dilation in the management of achalasia: Systematic review and meta-analysis, F Kamal, M A. Khan, M Bayoumi, H K. Marella, S Khan, Z Khan, Khwaja F. Haq, C W. Howden, C Tombazzi, and M K. Ismail
Urgent vs. Elective colonoscopy for lower gastrointestinal bleeding: Meta-analysis of randomized controlled trials, F Kamal, M A. Khan, H K. Marella, Y K. Reddy, Khwaja F. Haq, M Bayoumi, H Akbar, R P. Heda, and C Tombazzi
Risk factors for delayed post-polypectomy bleeding: Systematic review and meta-analysis, F Kamal, M A. Khan, Y K. Reddy, Khwaja F. Haq, R P. Heda, R Tariq, M K. Ismail, C Tombazzi, and C W. Howden
Endoscopic vs. Surgical resection for gastric gastrointestinal stromal tumors <5cm in size: Systematic review and>meta-analysis, F Kamal, M A. Khan, A Talat, C Gilman, H MS Arshad, Khwaja F. Haq, S Khan, D Ahmad, and C Tombazzi
Assessing respiratory complications in patients with obesity and obstructive sleep apnea undergoing a screening colonoscopy with moderate and deep sedation, Randeep Kaur, Ivan M. Columbus Morales, Taha Ashraf, Simran K. Bhatti, Faisal M. Nimri, and Anas Kutait
Efficacy and safety of self-expandable metal stents for management of bariatric surgery leaks. A systematic review and meta-analysis, M A. Khan, M Saumoy, U Iqbal, Khwaja F. Haq, A Khan, F Kamal, Tobias Zuchelli, H Anwar, M K. Mohammed Abdul, and R Z. Sharaiha
EFFECTS OF AGING AND ACUTE-ON-CHRONIC LIVER FAILURE ON LIVER TRANSPLANT WAITLIST MORTALITY, Toshihiro Kitajima, Yasutaka Kuno, Nicole Sukkarieh, Yukiko Suzuki, Shingo Shimada, Alexander Flores, Eric Lisznyai, Kelly Collins, Atsushi Yoshida, Michael Rizzari, Dilip Moonka, Marwan S. Abouljoud, and Shunji Nagai
Assessment of sarcopenia and obesity by bioelectrical impedance analysis in transplant and hepatobiliary populations, J Konel, Toshihiro Kitajima, L Arevalo, N Murray, Thomas Pietrowsky, Deepak Venkat, Humberto C. Gonzalez, Milagros Samaniego-Picota, Marwan S. Abouljoud, and Shunji Nagai
LIVER TRANSPLANTATION IN OLDER PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE: AN ANALYSIS OF UNOS REGISTRY, Yasutaka Kuno, Toshihiro Kitajima, Dilip Moonka, Nicole Sukkarieh, Alexander Flores, Eric Lisznyai, Shingo Shimada, Yukiko Suzuki, Kelly Collins, Michael Rizzari, Atsushi Yoshida, Marwan S. Abouljoud, and Shunji Nagai
Efficacy and safety of switching to tenofovir alafenamide (TAF) in virally-suppressed chronic hepatitis B patients (CHB) with renal impairment: Week 24 results, C W. Long, H Yi-Hsiang, L Young-Suk, J G. Edward, A S. Hoon, T TY Owen, H Jeong, H A. Josun, E Magdy, C Chi-Yi, S Wei-Wen, F John, G Anuj, Y J. Leland, S Shalini, J Belinda, M Shuyuan, Syed-Mohammed Jafri, and L AJ Harry
IMPACT OF HISTORY OF CHRONIC VIRAL HEPATITIS AND LIVER FIBROSIS ON RISK OF HOSPITALIZATION AND DEATH AMONG PATIENTS WITH SARS-COV-2 INFECTION, Mei Lu, Loralee B. Rupp, J A. Boscarino, M A. Schmidt, Y Daida, Yueren Zhou, Sheri Trudeau, Jia Li, and Stuart C. Gordon
LIVER TRANSPLANT EVALUATION IN THE PETH ERA, Sandra Naffouj, Ranya Selim, Omar Shamaa, Abdelwahab Ahmed, Yueren R. Zhou, Loralee B. Rupp, Syed M. Jafri, Stuart C. Gordon, and Humberto C. Gonzalez
THE IMPLICATIONS OF CHRONIC OPIOID USE ON POST-TRANSPLANT CLINICAL OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS, Sandra Naffouj, Mohammad A. Siddiqui, Amna Shaikh, Nawal Shabbir, Aimun Shabbir, and Reena J. Salgia
USE OF NEURAL NETWORK MODELS TO PREDICT MORTALITY/ SURVIVAL AMONG PATIENTS ON THE LIVER TRANSPLANT WAITLIST, Shunji Nagai, Anubhav Reddy Nallabasannagari, Dilip Moonka, Madhu Reddiboina, Michael Nanna, Lucy Chau, Sirisha Yeddula, Toshihiro Kitajima, Iman Bajjoka-Francis, and Marwan S. Abouljoud
960 Maximizing success in single-session edge - predictive factors of stent migration, B Shinn, T Boortalary, I Raijman, J Nieto, H S. Khara, S V. Kumar, B Confer, D L. Diehl, M AAN El Halabi, Y Ichkhanian, T M. Runge, V Kumbhari, M A. Khashab, A Tyberg, H M. Shahid, A Sarkar, M Gaidhane, R Bareket, M Kahaleh, Cyrus Piraka, Tobias Zuchelli, R Law, A R. Sondhi, P Kedia, J S. Robbins, C Calogero, M Bakhit, A L. Chiang, A Schlachterman, T E. Kowalski, and D E. Loren
LIVER INJURY IS ASSOCIATED WITH INCREASED MORBIDITY AND MORTALITY IN COVID-19 PATIENTS, Mohammad A. Siddiqui, Suraj Suresh, Mouhanna Abu Ghanimeh, Megan Karrick, Faisal M. Nimri, Maher Musleh, Vivek Mendiratta, Mustafa Al-Shammari, Stephen Simmer, Jessica Jou, Sarah Russell, Duyen Y. Dang, Reena J. Salgia, and Tobias Zuchelli
CLINICAL OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS WITH CHRONIC LIVER DISEASE AND CIRRHOSIS, Suraj Suresh, Mohammad Siddiqui, Mouhanna Abu Ghanimeh, Faisal M. Nimri, Megan Karrick, Maher Musleh, Vivek Mendiratta, Sarah Russell, Jessica Jou, Stephen Simmer, Mustafa Al-Shammari, Duyen Dang, and Tobias Zuchelli
Accuracy of agitated saline contrast echocardiography for assessment of intracardiac shunting in preoperative liver transplant patients, Benjamin Swanson, Reena Salgia, Jaber El-Bashir, and Sachin Parikh
Recurrence rate and risk factors following cold snare endoscopic mucosal resection of polyps ≥20 mm in size, Jinyu Zhang, Suraj Suresh, Abdelwahab Ahmed, Cyrus Piraka, Mouhanna Abu Ghanimeh, Robert Pompa, Sumit Singla, Duyen Dang, Mahmoud Isseh, Ahmed Elbanna, Randeep Kaur, and Tobias Zuchelli
Submissions from 2019
170 Post ERCP de novo fever and de novo bacteremia: Insights from the national inpatient database, A Bhurwal, H R. Mutneja, Khwaja F. Haq, M Bartel, and B Brahmbhatt
The Treatment of Hepatitis C Virus (HCV) with Direct Acting Antiviral (DAA) Treatment in the Post Orthotopic Liver Transplant (OLT) Patient Is Safe and Efficacious, P Brown, Zachary Demertzis, and Syed-Mohammed Jafri
Predictors and Outcomes of Acute Graft-Versus-Host Disease After Liver Transplant, Allyce Caines, Shunji Nagai, and Reena Salgia
Prediction of delayed graft function in combined liver-kidney transplantation: An analysis using the UNOS registry, Lucy Chau, M Safwan, Dilip Moonka, Dean Kim, Atsushi Yoshida, Marwan S. Abouljoud, and Shunji Nagai
Sofosbuvir/Velpatasvir Is Effective and Safe in Patients with Concomitant Proton PUMP Inhibitor Use in Clinical Studies, C Cooper, K Agarwal, J L. Calleja, J F. Dufour, S L. Flamm, Stuart C. Gordon, L Stamm, L Ni, D Brainard, A A. Cumaraswamy, K Kowdley, R Esteban, J A. Pineda, L Castells, M Buti, and S Lens
Sofosbuvir/Velpatasvir is effective and safe in patients with concomitant proton pump inhibitor use in clinical studies., R Esteban, K Agarwal, C L. Jose, F J. Dufour, S L. Flamm, Stuart C Gordon, W Y. Lu, C Lu, L Stamm, Y L. Ni, D Brainard, K V. Kowdley, C Cooper, P A. Juan, L Castells, M Buti, and S Lens
Evaluation of Liver Transplantation Among Advanced Age Recipients in a Large Multicenter U. S. Cohort, A Goel, A Kwong, D Devuni, C Wang, J Boike, J Jo, L Van Wagner, M Serper, L Jones, R Sharma, E Vema, J Shor, M German, A Hristov, A Lee, E Slengler, A Koteish, G Sehmbey, A Seetharam, N John, Y Patel, M Kappus, T Couri, Reena Salgia, Q Nhu, C Frenette, and J Lai
More than 4 times higher healthcare costs for end-stage liver disease patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, Stuart C. Gordon, N Kachru, S Sanatan, D Martinez, M Moynihan, and R Wong
Substantial healthcare utilization (HCU) and costs among nonalcoholic steatohepatitis (NASH) patients with comorbid diabetes mellitus (DM): Real-world analysis of 2007-2015 US medicare data., Stuart C Gordon, S Li, Y Peng, X Wang, and R Wong
Fibrosis-4 score (FIB-4) provides consistent assessment of healthcare costs and healthcare resource utilization (HCRU) among Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) patients with advanced fibrosis., Stuart C. Gordon, B Ozbay, E Parker, S Korrer, and R Wong
PIN26 Cost-minimization analysis of pan-genotypic treatment regimens for chronic hepatitis C, Stuart C. Gordon, N Smith, and D Dieterich
Inadequate response to UDCA among PBC patients under routine care in the US: Rising serum bilirubin even in the normal range is a risk factor and subsequent clinical follow-up differs based on treatment response, Stuart C. Gordon, Talan Zhang, C L. Bowlus, K D. Lindor, R J. Romanelli, I V. Haller, H Anderson, J J. Vanwormer, J A. Boscarino, M A. Schmidt, Y G. Sahota, J Vincent, Kuan-Han Wu, Sheri Trudeau, Christina Melkonian, Loralee B. Rupp, and Mei Lu
Effect of treatment of hepatitis B patients with tenofovir disoproxil or entecavir on risk of hepatocellular cancer death in a U.S. Cohort, Stuart C. Gordon, Yueren Zhou, Jian Li, Loralee B. Rupp, J A. Boscarino, Y G. Daida, M A. Schmidt, Sheri Trudeau, and Mei Lu
Molecular analysis of rejection and injury in liver transplant biopsies: The INTERLIVER STUDY, P Halloran, A Montano-Loza, Marwan S. Abouljoud, Dilip Moonka, T Reichman, G McCaughan, M Myslak, K Jurczyk, K Zieniewicz, M Grat, and A Perkowska-Ptasiμ Ska
An Unusual Case of Bleeding Gastric Varices Secondary to Metastatic Ovarian Adenocarcinoma, Randeep Kaur, Reena Salgia, Crystal Seudeal, and Eric Scher
Patients with Biliary Complications Following Orthotopic Liver Transplantation Can Be Successfully Managed by Serial Endoscopic Retrograde Cholangio-Pancreatography, R Kaur, I C. Morales, Dilshan Dhillon, M S. Ilias, Shunji Nagai, Deepak Venkat, Atsushi Yoshida, and Syed-Mohammed Jafri
Monitoring and Management of Proteinuria Is Often Ignored in Patients Receiving mTOR Therapy Following Orthotopic Liver Transplantation, R Kaur, Omar Sadiq, Maryam Alimirah, F Kumssa, A Patel, and Syed-Mohammed Jafri
Correlation Between Bilirubinemia and Acute Kidney Injury in Patients with Cirrhosis, Adrienne Lenhart, P Brown, Omar Khan, Maryam Alimirah, Hafsa Abdulla, Reena Salgia, and Junior Uduman
Complications of chronic hepatitis B: Prevalence and disparities in a US health system cohort 2006-2016, Mei Lu, Yueren Zhou, Jian Li, Loralee B. Rupp, J A. Boscarino, Y G. Daida, M A. Schmidt, Sheri Trudeau, and Stuart C. Gordon
Seladelpar for the treatment of primary biliary cholangitis: Experience with 26 cirrhotic patients, M J. Mayo, C Bowlus, G Michael, G Neff, P Trivedi, A Goel, J Odin, B Bacon, B Borg, Stuart C. Gordon, A Gulamhusein, S Harrison, C Levy, C Stanca, J Vierling, A Steinberg, M Varga, J Nguyen, S Bergheanu, Y J. Choi, M Standen, and P Boudes
Extreme hyponatremia as a risk factor for early mortality after liver transplantation in the model for end-stage liver disease-sodium period, H Mouzaihem, M Safwan, L Chau, Marwan Abouljoud, Dilip Moonka, and Shunji Nagai
Share 21 Rather Than Share 15: Balancing Transplant Opportunity Without Compromising Waitlist Outcomes, Shunji Nagai, Lucy Chau, Marwan S. Abouljoud, Kelly Collins, Syed-Mohammed Jafri, M Safwan, and Dillip Moonka
Patients with non-alcoholic steatohepatitis have inferior liver transplant outcomes, Shunji Nagai, Kelly Collins, Lucy C. Chau, Michael D. Rizzari, Atsushi Yoshida, Marwan S. Abouljoud, M Safwan, and Dillip Moonka
Effects of major liver allocation policy changes on waitlist outcomes in multivisceral transplantation in the United States, Shunji Nagai, Yakir Muszkat, Michael Rizzari, Syed-Mohammed Jafri, and Marwan Abouljoud
Effects of Major Liver Allocation Policy Changes on Waitlist Outcomes in Multivisceral Transplantation, Shunji Nagai, Michael Rizzari, Yakir Muszkat, Kelly Collins, Atsushi Yoshida, Syed-Mohammed Jafri, and Marwan Abouljoud
Fatal Graft Versus Host Disease in Liver Transplantation: An Analysis of UNOS Registry, Shunji Nagai, Atsushi Yoshida, Reena Salgia, Marwan Abouljoud, and Dilip Moonka
A National Survey of Immunosuppression Strategies in Intestinal Transplantation, M C. Segovia, T Beduschi, J Boike, D Farmer, S Horslen, K Iyer, Syed-Mohammed Jafri, A Langnas, C Matsumoto, A Mavis, G Mazariegos, Shunji Nagai, J O'Leary, Y Patel, D Sudan, Nimisha Sulejmani, Bryant B. Summers, and T Schiano
A Multicenter Study of mTor Inhibitor Use in Intestine and Multivisceral Transplantation, M C. Segovia, A Mavis, J Boike, Y Patel, T Schiano, and Syed-Mohammed Jafri
Safety and efficacy of mTOR inhibitors following intestine and multivisceral transplantation, M C. Segovia, D Sudan, Shunji Nagai, Yakir Muszkat, A Mavis, T Schiano, and Syed-Mohammed Jafri
Perioperative Lactate Levels Are Sensitive Marker to Predict Early Allograft Dysfunction and Short-Term Graft Failure After Liver Transplant, K Takahashi, Shunji Nagai, Kelly Collins, Michael Rizzari, M Safwan, Syed-Mohammed Jafri, T Oda, Atsushi Yoshida, and Marwan S. Abouljoud
Management of Anastomotic Biliary Strictures After Liver Transplant: Role of Covered Metal Stents, Andrew Watson, Khwaja F. Haq, Kamal Khorfan, Sumit Singla, Atsushi Yoshida, and Dilip Moonka
Rising and higher healthcare-resource-utilization (HCRU) and costs of Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH) patients with advanced liver disease-a US real-world-analysis., R Wong, N Kachru, N Meyer, and Stuart C Gordon
Submissions from 2018
The roles of therapeutic plasmapheresis (TPE) and extracorporeal photopheresis (ECP) for the treatment of liver allograft rejection., Beena U. Ahsan, A Eisenbrey, Mohammad Raoufi, Dilip Moonka, and Ileana Lopez-Plaza
Effect of SVR on liver-related and all-cause hospitalization of patients with chronic HCV infection: The chronic hepatitis cohort study (CHECS), 2014-16., R Augustine, J Xing, P R. Spradling, A C. Moorman, Loralee B. Rupp, Stuart C. Gordon, Mei Lu, J A. Boscarino, M A. Schmidt, Y Daida, S D. Holmberg, and E H. Teshale
Efficacy and safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis: 52-week analysis of an ongoing international, randomized, dose ranging phase 2 study., C L. Bowlus, G Neff, R Aspinall, Michael R. Galambos, A Goel, Gideon M. Hirschfield, Andreas E. Kremer, M J. Mayo, Mark G. Swain, B Borg, Y Dorffel, Stuart C. Gordon, S Harrison, D Jones, Paul J. Thuluvath, C Levy, D AS Heridan, C Stanca, Bruce R. Bacon, B Berg, Tarek Hassanein, J Odin, Mitchell L. Shiffman, D Thorburn, John M. Vierling, David Bernstein, Peter Buggisch, Linsey Corless, Charles S. Landis, A L. Peyton, Shah H. A, M A. Woerns, Norman Gitlin, A Steinberg, S Bergheanu, Chad Amato, G Amato, Yun-Jung Choi, S Rosenbusch, M Varga, Charles A McWherter, and P Boudes
International multicenter study on digital single operator pancreatoscopy for the management of pancreatic stones., O I. Brewer Gutierrez, I Raijman, B J. Elmunzer, G Webster, D K. Pleskow, S Sherman, R Sturgess, D V. Sejpal, C Ko, A Maurano, D G. Adler, Daniel Mullady, D S. Strand, C J. DeMaio, Cyrus Piraka, R Z. Sharaiha, M Dbouk, S Han, C Spyceland, N Bekkali, M Gabr, B L. Bick, L K. Dwyer, D Han, J Buxbaun, C Zulli, N Cosgrove, A Y. Wang, D L. Carr-Locke, T Kerdsirichairat, H Aridi, R Moran, S Shah, J Yang, O Sanaei, Davinder Parsad, N Parsa, V Kumbhari, V Singh, and M A. Khashab
One-year outcomes in patients with advanced liver fibrosis or compensated cirrhosis from chronic hepatitis C receiving kidney transplant alone., P Brown, Fitsum Kumssa, and Deepak Venkat
Elbasvir-grazoprevir (Zepatier) is effective and safe for the treatment of chronic hepatitis C (HCV) genotype 1 virus in the post kidney transplant patient. Am J Transplant 2018; 18:941., P Brown and Deepak Venkat
Regional variation in the outcomes of meld-na based liver allocation., Lucy Chau, Dilip Moonka, Kelly Collins, Michael Rizzari, Atsushi Yoshida, Marwan S. Abouljoud, and Shunji Nagai
Sofosbuvir/velpatasvir is effective and safe in patients with concomitant proton pump inhibitor use in clinical studies, R Esteban, K Agarwal, Jose L Calleja, Jean-Francois Dufour, Steven L Flamm, L Ni, Stuart C Gordon, L Stamm, D Brainard, K V Kowdley, C Cooper, J A. Pineda, L Castells, M Buti, and S Lens
Increasing healthcare resource utilization (HCRU) and costs associated with advanced liver disease-a multivariate analyses of real-world medicare nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/ NASH) patients., Stuart C. Gordon, Jeremy Fraysse, L Li, and Richard J. Wong
Comparative analysis of direct-acting antiviral regimens across Hepatitis C genotypes and clinical characteristics among patients under routine clinical care in the US., Stuart C. Gordon, S D. Holmberg, A C. Moorman, P R. Spradling, E H. Teshale, J A. Boscarino, Y Daida, M A. Schmidt, Kuan-Han Wu, Loralee B. Rupp, Talan Zhang, Sheri Trudeau, and Mei Lu
Substantial healthcare utilization (HCU) and costs among nonalcoholic steatohepatitis (NASH) patients with comorbid diabetes mellitus (DM): Real-world analysis of 2007-2015 US Medicare data., Stuart C. Gordon, S Li, Y Peng, X Wang, and R Wong
Fibrosis-4 score (FIB-4) provides consistent assessment of healthcare costs and healthcare resource utilization (HCRU) among nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients with advanced fibrosis., Stuart C Gordon, B Ozbay, E Parker, S Korrer, and Richard J Wong
Serum bilirubin within normal range is associated with an increasing risk of mortality in patients with primary biliary cholangitis regardless of ursodeoxycholic acid treatment. Hepatology 2018; 68:31A-32A., Stuart C. Gordon, C Rodriguez, R J. Romanelli, I V. Haller, H Anderson, J J. VanWormer, J A. Boscarino, M A. Schmidt, Y Daida, A K. Sahota, J L. Vincent, C L. Bowlus, Talan Zhang, Sheri Trudeau, J Li, Christina Melkonian, Kuan-Han Wu, Loralee B. Rupp, and Mei Lu
Effect of seladelpar on pruritus in primary biliary cholangitis: 26-week analysis of an ongoing international, randomized, dose ranging phase 2 study. Hepatology 2018; 68(1):1464A-1465A., Andreas E. Kremer, C L. Bowlus, G Neff, R Aspinall, Michael R. Galambos, A Goel, Gideon M. Hirschfield, M J. Mayo, Mark G. Swain, B Borg, Y Dorffel, Stuart C. Gordon, S A. Harrison, D Jones, Paul J. Thuluvath, John M. Vierling, D Bernstein, Peter Buggisch, Linsey Corless, C SL Andis, A L. Peyton, H A. Shah, M A. Woerns, Norman Gitlin, A Steinberg, S Bergheanu, G Amato, Yun-Jung Choi, S Rosenbusch, M Varga, Charles A. McWherter, and P Boudes
Safety and efficacy of treatment with once-daily ledipasvir/sofosbuvir (90/400 mg) for 12 weeks in genotype 1 hcv-infected patients with severe renal impairment., Eric Lawitz, Charles S Landis, Benedict Maliakkal, M Bonacini, G Ortiz-Lasanta, J Zhang, E Mogalian, S De-Oertel, Anu Osinusi, Diana M Brainard, John G McHutchison, CSM Yip, HC Huang, Steven L Flamm, Stuart C Gordon, and Edward J Gane
Epidemiological trends of chronic hepatitis b among routine clinical care patients in the US (2006-2015)., Mei Lu, Jia Li, S D. Holmberg, A C. Moorman, P R. Spradling, E H. Teshale, J A. Boscarino, Y Daida, M A. Schmidt, Yueren Zhou, Loralee B. Rupp, Talan Zhang, Sheri Trudeau, and Stuart C. Gordon
Hepatitis C patients with HIV co-infection demonstrate unique liver-related complications and health behaviors compared to HCV mono-infected patients., Mei Lu, Norman Markowitz, Yueren Zhou, Kuan-Han H. Wu, Loralee B. Rupp, Sheri Trudeau, J A. Boscarino, M A. Schmidt, Y G. Daida, and Stuart C. Gordon
HIV co-infection is associated with increased liver complications and reduced mental health among patients with chronic hepatitis B., Mei Lu, Norman Markowitz, Yueren Zhou, Kuan-Han H. Wu, Loralee B. Rupp, Sheri Trudeau, J A. Boscarino, M A. Schmidt, Y G. Daida, and Stuart C. Gordon
The safety and tolerability of sof/vel/vox for 8 or 12 weeks in > 1,000 patients treated in the polaris-1, polaris-2, polaris-3, and polaris-4 studies: An integrated analysis., Michael P. Manns, Edward Gane, B E. Willems, Stuart K. Roberts, S L. Flamm, Marc Bourliere, Tarik Asselah, L Alric, Robert H. Hyland, Luisa M. Stamm, K C. Huang, Diana M. Brainard, C SM Yip, H C. Huang, M Khalili, Graham R. Foster, Stuart C. Gordon, R K. Rajender, Stefan Zeuzem, Ira M. Jacobson, Curtis L. Cooper, A J. Thompson, K V. Kowdley, and Eric Lawitz
Factors influencing post-transplant mortality in primary biliary cholangitis., Vivek Mendiratta, K Alsafadi, and Deepak Venkat
Predictors of hepatic encephalopathy in cirrhotic patients undergoing elective transjugular intrahepatic portosystemic shunt, Vivek Mendiratta, Fitsum Kumssa, and Deepak Venkat
Albumin and age as independent predictors of 1 year mortality in cirrhotic patients undergoing elective tips., Vivek Mendiratta, Kajali Mishra, H Abdulla, and Deepak Venkat
The impact of spontaneous bacterial peritonitis on patient outcomes after liver transplantation using the scientific registry of transplant recipient (SRTR) database, Dillip Moonka, George W. Divine, and Shunji Nagai
Presence of advanced liver disease concurrent with initial diagnosis of Hepatitis C virus (HCV) infection among patients in the chronic hepatitis cohort study (CHECS) 2014-16: Missed opportunities for intervention., A C. Moorman, J Xing, Loralee B. Rupp, Stuart C. Gordon, Mei Lu, P R. Spradling, J A. Boscarino, Y Daida, M A. Schmidt, S D. Holmberg, and E H. Teshale
MELD-Na score based liver allocation: Hyponatremia is no longer a risk factor for waitlist mortality., Shunji Nagai, Lucy Chau, Mohamed Safwan, Randolph E. Schilke, Michael Rizzari, Kelly Collins, Atsushi Yoshida, Marwan Abouljoud, and D Moonka
Survival benefit of liver transplantation in the MELD-Na era., Shunji Nagai, Lucy Chau, M Safwan, R Schilke, Michael Rizzari, Kelly Collins, Atsushi Yoshida, Marwan S. Abouljoud, and D Moonka
